Proteomics in investigation of cancer metastasis: functional and clinical consequences and methodological challenges

Area of Science:

• Oncology and Molecular Biology
• Cancer Research
• Biochemistry

Background:

• Metastasis is the primary cause of cancer-related mortality in solid tumors.
• Understanding the molecular mechanisms of the metastatic cascade is critical for developing effective therapies.
• There is an urgent need for novel therapeutic targets and biomarkers for metastatic disease.

Purpose of the Study:

• To review the role of proteomics in identifying metastasis-associated proteins and biomarkers.
• To analyze the methodological aspects of proteomics approaches in cancer research.
• To discuss the contribution of proteomics to understanding the functional characterization and interactome of proteins in the metastatic cascade.

Main Methods:

• Proteomics analysis of cancer tissues, microdissected cells, model systems, and secretomes.
• Identification of metastasis-associated proteins and potential biomarkers.
• Functional experiments and verification of protein expression profiles and biological roles.
• Interactome analysis of proteins involved in the metastatic cascade.

Main Results:

• Proteomics has successfully identified numerous metastasis-associated proteins and potential biomarkers.
• Key protein expression profiles and biological roles have been validated through functional experiments.
• Current proteomics approaches contribute significantly to understanding protein functions and interactions in metastasis.

Conclusions:

• Proteomics is a powerful tool for unraveling the complexities of cancer metastasis.
• Continued advancements in proteomics technologies will enhance our ability to answer critical clinical and functional questions.
• Proteomics offers promising avenues for discovering new therapeutic targets and biomarkers for metastatic cancers.